Steris PLC (NYSE:STE) shares reached a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $142.44 and last traded at $142.37, with a volume of 20411 shares. The stock had previously closed at $140.45.
Several research firms have issued reports on STE. JMP Securities increased their price objective on Steris from $135.00 to $150.00 and gave the stock a “market outperform” rating in a research report on Wednesday, May 22nd. Stephens increased their price objective on Steris from $135.00 to $150.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 15th. KeyCorp increased their price objective on Steris from $135.00 to $138.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 15th. Finally, Zacks Investment Research upgraded Steris from a “hold” rating to a “buy” rating and set a $146.00 price objective for the company in a research report on Tuesday, April 30th. Five investment analysts have rated the stock with a buy rating, Steris has an average rating of “Buy” and a consensus price target of $148.20.
The stock has a market cap of $12.05 billion, a price-to-earnings ratio of 28.84 and a beta of 0.96. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.27 and a quick ratio of 1.82.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 28th. Investors of record on Wednesday, June 12th will be paid a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.97%. The ex-dividend date of this dividend is Tuesday, June 11th. Steris’s payout ratio is currently 27.81%.
In other Steris news, Director Richard Martin Steeves sold 72,867 shares of the firm’s stock in a transaction dated Thursday, June 6th. The stock was sold at an average price of $136.78, for a total value of $9,966,748.26. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Walter M. Rosebrough, Jr. sold 119,000 shares of the firm’s stock in a transaction dated Friday, May 31st. The stock was sold at an average price of $132.56, for a total value of $15,774,640.00. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 259,785 shares of company stock worth $34,402,980. Corporate insiders own 2.36% of the company’s stock.
A number of large investors have recently modified their holdings of STE. Pinebridge Investments L.P. acquired a new position in shares of Steris in the 1st quarter valued at about $50,000. Rockefeller Capital Management L.P. acquired a new position in shares of Steris in the 1st quarter valued at about $54,000. Advisory Services Network LLC lifted its stake in shares of Steris by 26.0% in the 4th quarter. Advisory Services Network LLC now owns 427 shares of the medical equipment provider’s stock valued at $45,000 after purchasing an additional 88 shares in the last quarter. Executive Wealth Management LLC acquired a new position in shares of Steris in the 4th quarter valued at about $47,000. Finally, Enlightenment Research LLC acquired a new position in shares of Steris in the 4th quarter valued at about $53,000. 83.37% of the stock is currently owned by hedge funds and other institutional investors.
TRADEMARK VIOLATION WARNING: “Steris (NYSE:STE) Sets New 12-Month High at $142.44” was originally posted by Markets Daily and is owned by of Markets Daily. If you are accessing this report on another site, it was illegally stolen and republished in violation of United States & international trademark & copyright law. The legal version of this report can be read at https://www.themarketsdaily.com/2019/06/14/steris-nyseste-sets-new-12-month-high-at-142-44.html.
About Steris (NYSE:STE)
STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.
Featured Story: What is the price-to-earnings growth (PEG) ratio?
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.